Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

OBJECTIVES: Report long-term safety and effectiveness of natalizumab over 240 weeks in the prospective, observational, open-label Safety of TYSABRI Re-dosing and Treatment (STRATA) Study. METHODS: Patients (N = 1,094) previously enrolled in natalizumab multiple sclerosis clinical trials received nat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: O'Connor, Paul, Goodman, Andrew, Kappos, Ludwig, Lublin, Fred, Polman, Chris, Rudick, Richard A., Hauswirth, Kathy, Cristiano, Lynda M., Forrestal, Fiona, Duda, Petra
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4114173/
https://ncbi.nlm.nih.gov/pubmed/24898925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados